BASF to increase 1,2-PDA capacity with new China plant

By Gareth Macdonald contact

- Last updated on GMT

BASF to increase 1,2-PDA capacity with new China plant

Related tags: Active pharmaceutical ingredients, Manufacturing

BASF has announced plans for a specialty amines plant at its site on the Nanjing Chemical Industry Park in China, citing increasing demand from customers in Asia.

The plan – which is due to be operational in 2019 – will make a range of amines including 1,2-Propylenediamine (1,2-PDA), which is used as a building block in the manufacture of a wide range of active pharmaceutical ingredients (API).

Narayan Krishnamohan, senior VP of BASF’s intermediates business in Asia Pacific, said: “This investment will help us to meet the increasing Asia Pacific demand for specialty amines used as intermediates in a diverse range of industries and applications.”

Related news

Show more

Related products

show more

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Related suppliers

Follow us

Products

View more

Webinars